|
Volumn 27, Issue 8, 2001, Pages 857-862
|
Terfenadine-β-cyclodextrin inclusion complex with antihistaminic activity enhancement
a b a a a c c a a |
Author keywords
Antihistaminic activity; Inclusion; Solubility; Terfenadine
|
Indexed keywords
ANTIHISTAMINIC AGENT;
BETA CYCLODEXTRIN;
TERFENADINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG FORMULATION;
DRUG POTENCY;
DRUG SOLUBILITY;
HISTAMINE BLOOD LEVEL;
HISTAMINE RELEASE;
MALE;
MATHEMATICAL COMPUTING;
NONHUMAN;
PH;
POWDER;
RAT;
ALGORITHMS;
ANIMALS;
BETA-CYCLODEXTRINS;
CALORIMETRY, DIFFERENTIAL SCANNING;
CHEMISTRY, PHYSICAL;
CYCLODEXTRINS;
EXCIPIENTS;
HISTAMINE H1 ANTAGONISTS;
HISTAMINE RELEASE;
HYDROGEN-ION CONCENTRATION;
KINETICS;
MALE;
PASSIVE CUTANEOUS ANAPHYLAXIS;
POWDERS;
RATS;
RATS, SPRAGUE-DAWLEY;
SOLUBILITY;
SPECTROPHOTOMETRY, ULTRAVIOLET;
TERFENADINE;
|
EID: 0034752911
PISSN: 03639045
EISSN: None
Source Type: Journal
DOI: 10.1081/DDC-100107250 Document Type: Article |
Times cited : (50)
|
References (15)
|